Listen to this page using ReadSpeaker

Despite Blindness, the Peaches are Sweet in Paran

Ignacio, a farmer with RP, tends to his peach orchard in Peru.Paran, a village of 300 people tucked in the foothills of the Andes near Lima, Peru, is known for its sweet peaches, but also its high rate of blindness. About one in eight Paranos have lost their vision.

Until recently, the villagers never understood the cause of the affliction, though they suspected there might be a genetic component because it runs in families. However, most had never even received care from a doctor.

But a visit from Ricardo Fujita, Ph.D., a genetic scientist at the University of San Martin de Porres in Lima, helped shed light on Paran’s blindness. He was dispatched to Paran by doctors who had been part of a medical outreach effort initiated by a mining company.

“Dr. Marco Valverde learned of my previous work with retinitis pigmentosa at the University of Michigan, where I worked with Dr. Anand Swaroop in the late 1990s. He invited me to visit Paran in a campaign with the ophthalmologists,” explained Dr. Fujita, who returned to Peru after his postdoctoral studies at Michigan.

Because of the early symptoms, which include night blindness and loss of peripheral vision, the ophthalmology team suspected retinitis pigmentosa (RP) was the culprit. The fact that mostly males were affected led Dr. Fujita to believe it was the X-linked form, in which women are carriers of the condition but usually don’t suffer vision loss. His genetic study confirmed X-linked RP (XLRP) caused by a mutation in the RPGR gene.

The good news is that the Foundation Fighting Blindness is funding development of an XLRP gene therapy. Gus Aguirre, V.M.D., Ph.D., and William Beltran, V.M.D., Ph.D., at the University of Pennsylvania, are conducting pre-clinical studies in preparation for a human trial of an XLRP gene therapy to be launched by Applied Genetic Technologies Corporation.

However, getting the villagers access to the emerging treatment could be challenging. Paran, located in rugged highlands, is a four-hour car trip from Lima. Also, some of the town’s leaders are reluctant to get involved in medical research.

Dr. Fujita says that prevalent blindness and the diagnosis of XLRP have led to some unwarranted negative publicity for Paran’s peach business. “For most of them, blindness is not an impediment to working in their peach orchards. They know the orchards by heart, some of which are kilometers away from their homes across rocky terrain,” he explains. “Peaches are their lives. They aren’t asking for anything more.”

Yet, Dr. Fujita believes that eradicating the town’s blindness would have a beneficial impact. “It would be great,” he says, “to find a cure for the people of Paran.”

Photo, above: Ignacio, who’s affected by retinitis pigmentosa, walks to his peach orchard in Peru.

 


7 Responses to 'Despite Blindness, the Peaches are Sweet in Paran'

  1. kailash kushwaha says:

    I AM suffering from rp; I loss my vission’ please advise me about treatment.

  2. alex says:

    I to have RP ITS BEEN A STRUGGLE FOR MY BROTHER AND I TO LIVE LIFE PLEASE I HELP US AND EVERY ONE ELSE THAT HAS TO LIVE WITH THIS I LIVE IN CONNECTICUT PLEASE HELP I WANT TO SEE MY DAUGHTER GROW UP WITH ME SEEING HER PLEASE FIND IT IN YOUR HEART TO HELP US THANK YOU

  3. Sushil dangi says:

    I have RP pl.give addres where the tratement of RP

  4. George Cu says:

    I have an RP. I lost my vision 5 years ago. I am supporting 8 children. I don’t know anymore what they all look like as well as my granddaughter whose 2 years old now. I’m really hoping that there’s still a chance to recover my eyesight. Please help us out who are in deeply need for us to be able to fulfill our duties and responsibilities as a Father. Thank you.

    • EyeOnTheCure says:

      We are working non-stop to raise funding for research that will lead to treatments and cures for all forms of retinal disease, including RP. At the present time, the only treatment that offers a chance of sight restoration for individuals who have lost their sight is implantation with the Argus-2 visual prosthetic device. Stem cell / photoreceptor cell replacement and optogenetics are two other sight-restoration strategies that are being investigated but are not in clinical trials yet. While it is not perfect, the Argus-2 offers the possibility of improved navigation and other very low vision skills. If you are interested in this option, please see the following link to ClinicalTrials.Gov website listing for the post-marketing Argus-2 trial:
      https://clinicaltrials.gov/ct2/show/NCT01860092?term=second+sight&rank=3

  5. homemade says:

    Hi mates, its fantastic article regarding teachingand fully explained, keep it up all the
    time.

Leave a Reply

Your email address will not be published. Required fields are marked *

*